NEWS

Utopia SIS and Pariter Partners invest in Lighthouse Biotech

Lighthouse Biotech aims to define new boundaries for oncology research through new liquid biopsy technologies The investment will be the first to be guaranteed by Medio Credito Centrale for over 80% Milan, December 29, 2021 – Utopia SIS, an investment company...

Rigenera: platform for the production of decellularized matrices for cardiac regeneration

DESCRIPTION The project is part of the most recent trends in regenerative medicine (whose goal is to regenerate, replace, or repair damaged tissues or organs), such as the decellularization of animal and human hearts. This means the removal of immunogenic elements,...